Sale, M. J., Minihane, E., Monks, N. R., Gilley, R., Richards, F. M., Schifferli, K. P., . . . Cook, S. J. (2019). Targeting melanoma’s MCL1 bias unleashes the apoptotic potential of BRAF and ERK1/2 pathway inhibitors. Nature Portfolio.
Style de citation Chicago (17e éd.)Sale, Matthew J., et al. Targeting Melanoma’s MCL1 Bias Unleashes the Apoptotic Potential of BRAF and ERK1/2 Pathway Inhibitors. Nature Portfolio, 2019.
Style de citation MLA (8e éd.)Sale, Matthew J., et al. Targeting Melanoma’s MCL1 Bias Unleashes the Apoptotic Potential of BRAF and ERK1/2 Pathway Inhibitors. Nature Portfolio, 2019.
Attention : ces citations peuvent ne pas être correctes à 100%.